IRIS
FERRERI, ANDRES JOSE MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 998
NA - Nord America 856
AS - Asia 209
SA - Sud America 17
OC - Oceania 10
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.100
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 844
SE - Svezia 606
IT - Italia 142
FI - Finlandia 66
GB - Regno Unito 56
CN - Cina 42
IE - Irlanda 33
DE - Germania 30
JP - Giappone 26
IN - India 25
HK - Hong Kong 22
IR - Iran 16
KR - Corea 13
PT - Portogallo 13
SG - Singapore 11
ES - Italia 10
RU - Federazione Russa 10
SA - Arabia Saudita 10
TR - Turchia 10
AU - Australia 9
CL - Cile 7
FR - Francia 7
MX - Messico 7
NL - Olanda 7
EC - Ecuador 6
ID - Indonesia 6
GG - Guernsey 5
NO - Norvegia 5
CA - Canada 4
EG - Egitto 4
CH - Svizzera 3
IQ - Iraq 3
LB - Libano 3
PL - Polonia 3
TW - Taiwan 3
MA - Marocco 2
MM - Myanmar 2
MY - Malesia 2
OM - Oman 2
PE - Perù 2
PH - Filippine 2
PK - Pakistan 2
PS - Palestinian Territory 2
SY - Repubblica araba siriana 2
YE - Yemen 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
CO - Colombia 1
EE - Estonia 1
EU - Europa 1
MO - Macao, regione amministrativa speciale della Cina 1
MQ - Martinica 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PY - Paraguay 1
RO - Romania 1
VN - Vietnam 1
Totale 2.100
Salva come PNG Salva come JPEG
Città #
Lawrence 266
Princeton 266
Helsinki 65
New York 63
Ashburn 45
Milan 42
Dublin 33
Shanghai 27
Los Angeles 24
Hong Kong 21
Leicester 18
Tokyo 13
Daejeon 11
Naples 9
Washington 9
Fremont 8
Kish 8
Rome 8
Chicago 7
Mumbai 7
Pune 7
Rotherham 7
Santiago 7
Azogues 6
Jakarta 6
Borås 5
Boydton 5
Buccinasco 5
Guernsey 5
Moscow 5
Falkirk 4
Hoofddorp 4
Izmir 4
Makkah 4
Perugia 4
Seattle 4
Singapore 4
Adana 3
Andover 3
Augsburg 3
Barnet 3
Bologna 3
Brixen 3
Ciudad Nezahualcoyotl 3
Durham 3
Erbil 3
Hamm 3
Hanover 3
Krakow 3
League City 3
North Augusta 3
Pearland 3
Seville 3
Wednesbury 3
Ahmedabad 2
Albizzate 2
Alexandria 2
Arequipa 2
Aveiro 2
Barcelona 2
Blackheath 2
Boardman 2
Boston 2
Brisbane 2
Buk-gu 2
Buscate 2
Castelo do Neiva 2
Chennai 2
Dammam 2
Deiva Marina 2
Delhi 2
Egham 2
Foggia 2
Fort Gibson 2
Freiburg im Breisgau 2
Gaziantep 2
Guadalajara 2
Hackney 2
Hakusancho-sada 2
Jeddah 2
Jinan 2
Kasumicho 2
Kuala Lumpur 2
Kyauk Se 2
La Seyne-sur-Mer 2
Larkana 2
London 2
Melbourne 2
Mestre 2
Mexico City 2
Milwaukee 2
Montecorvino Pugliano 2
Muscat 2
Neem ka Thana 2
New Glasgow 2
Okayama 2
Oklahoma City 2
Oslo 2
Oujda 2
Paris 2
Totale 1.179
Salva come PNG Salva come JPEG
Nome #
Definition, diagnosis, and management of intravascular large B-Cell lymphoma: Proposals and perspectives from an international consensus meeting 212
Anti-CD20 monoclonal antibody (Rituximab) in gastric extranodal marginal zone (MALT) non-Hodgkin's lymphoma (NHL) patients: Clinical and biological results (Phase II study). 44
Chlamydia infection and lymphoma: Multiple detection methods highlight an association beyond lymphomas of the ocular adnexa 29
Liquid biopsy of cerebrospinal fluid enabling the detection and therapeutic targeting of the BRAFV600E mutation in a patient with overlapping Erdheim-Chester/Rosai-Dorfman disease 28
Cyclin D3 immunoreactivity (IR) is an independent predictor of survival and drives the correct assessment of p27(KIP1) IR prognostic role in primary gastric lymphomas (PGL). 28
Cyclin D3 (CyD3) immunoreactivity (IR) is an independent predictor of survival and drives the correct assessment of p27 IR prognostic role in primary gastric lymphomas (PGL) 23
Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy 23
R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma 20
Quantitative muscle mass biomarkers are independent prognosis factors in primary central nervous system lymphoma: The role of L3-skeletal muscle index and temporal muscle thickness 20
A PHASE II STUDY TO INVESTIGATE THE PREVALENCE OF INFECTIOUS AGENTS IN OCULAR ADNEXAE MARGINAL ZONE LYMPHOMA (OAMZL) AND THE EFFICACY OF ANTIBIOTIC THERAPY (IELSG#27 TRIAL) 19
Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG) 19
Graft-versus-lymphoma effect inside the central nervous system in a patient with extranodal natural killer/T-cell lymphoma, nasal type 19
Clinical Experience in a Large Cohort of Patients with Vitreoretinal Lymphoma in a Single Center 18
Chronic lymphocytic leukemia 15
A multicenter study of treatment of primary CNS lymphoma 15
A MULTICENTER TRIAL ASSESSING FEASIBILITY AND EFFICACY OF A COMBINATION OF HIGH-DOSE METHOTREXATE, CYTARABINE AND THIOTEPA IN PATIENTS WITH PRIMARY CNS LYMPHOMA: IMPACT ON OUTCOME OF CYTARABINE DOSE 15
Combined treatment with high-dose methotrexate, vincristine and procarbazine, without intrathecal chemotherapy, followed by consolidation radiotherapy for primary central nervous system lymphoma in immunocompetent patients 15
Breaching the blood–brain tumor barrier for tumor therapy 15
High-dose sequential chemoimmunotherapy supported by autologous stem cell transplantation in patients with systemic B-cell lymphoma and central nervous system involvement: interim analysis of a multicentre phase II Trial 14
Perivascular expression of CXCL9 and CXCL12 in primary central nervous system lymphoma: T-cell infiltration and positioning of malignant B cells 14
Anti-CD20 rechallenge with ofatumumab in relapsed/refractory splenic marginal zone lymphoma: the MORE trial 13
Bone Marrow Histopathology in the Diagnostic Evaluation of Splenic Marginal-zone and Splenic Diffuse Red Pulp Small B-cell Lymphoma: A Reliable Substitute for Spleen Histopathology? 13
Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma: Final results of a phase 2 trial 13
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: Results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial 13
Primary cardiac lymphoma in immunocompetent patients - Diagnostic and therapeutic management 12
A virtual tissue bank for primary central nervous system lymphomas in immunocompetent individuals 12
F-18-FDG pet after allogeneic stem cell transplantation in lymphoid malignancies: A useful tool to guide and monitor post-transplant immunotherapy 12
Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome 12
A reappraisal of the diagnostic and therapeutic management of uncommon histologies of primary ocular adnexal lymphoma 12
A Six-Month Regimen of Oral Clarithromycin Is a Feasible and Active Therapy for Patients with Relapsed/Refractory Marginal Zone B-Cell Lymphoma of MALT-Type 12
A PHASE II TRIAL TO INVESTIGATE THE LINK WITH INFECTIOUS AGENTS IN OCULAR ADNEXAL MARGINAL ZONE LYMPHOMA, ESPECIALLY WITH CHLAMYDIA SPECIES, AND THE ANTINEOPLASTIC EFFECTS OF DOXYCYCLINE (IELSG#27) 12
BCL2, BCL6, MYC, MALT 1, and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of fluorescent in situ hybridization probes and correlation with clinical outcome 12
Burden of Illness in Follicular Lymphoma with Multiple Lines of Treatment, Italian RWE Analysis 11
Central nervous system dissemination in immunocompetent patients with aggressive lymphomas: incidence, risk factors and therapeutic options 11
MATILDE chemotherapy regimen for primary CNS lymphoma Results at a median follow-up of 12 years 11
Randomized Phase II Trial on Primary Chemotherapy with High-Dose Methotrexate Alone or Associated with High-DoseCytarabine for Patients with Primary CNS Lymphoma (IELSG #20 Trial): Tolerability, Activity and Event-Free Survival Analysis 11
ABVD CAN BE SAFELY ADMINISTERED REGARDLESS OF ABSOLUTE NEUTROPHIL COUNT AND WITHOUT G-CSF SUPPORT IN HODGKIN'S LYMPHOMA PATIENTS 11
Chlamydia infection and lymphomas: association beyond ocular adnexal lymphomas highlighted by multiple detection methods 11
Determining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithms 10
ALK-negative anaplastic large cell lymphoma: Features and outcomes of 235 patients from the International T-Cell Project 10
Non-surgical treatment with primary chemotherapy, with or without radiation therapy, of stage I-II high-grade gastric lymphoma 10
Bugs and marginal zone lymphoma of the ocular adnexae: is the future already here? 10
Ocular Adnexal Lymphoma: Diffusion-weighted MR Imaging for Differential Diagnosis and Therapeutic Monitoring 10
Allografting for patients with advanced hematological malignancies: Non-myeloablative conditioning followed by the reinfusion of lymphocytes engineered with HSV thymidine kinase gene. 10
Chronic lymphocytic leukaemia 10
Prognostic significance of the histopathologic recognition of low- and high-grade components in stage I-II B-Cell gastric lymphomas 10
Questions and answers in the management of primary central nervous system and ocular lymphomas 10
A First-in-human Study of Tenalisib (RP6530), a Dual PI3K δ/γ Inhibitor, in Patients With Relapsed/Refractory Hematologic Malignancies: Results From the European Study 10
Primary central nervous system lymphoma 10
A dose-dense short-term therapy for human immunodeficiency virus/acquired immunodeficiency syndrome patients with high-risk Burkitt lymphoma or high-grade B-cell lymphoma: safety and efficacy results of the “CARMEN” phase II trial 9
Rituximab in patients with mucosal-associated lymphold tissue-type lymphoma of the ocular adnexa 9
The impact of histopathologic diagnosis on the proper management of testis neoplasms 9
Gains of CCND3 gene in ocular adnexal MALT lymphomas: an integrated analysis 9
Diffuse large B-cell lymphoma with concordant bone marrow involvement has peculiar genomic profile and poor clinical outcome 9
Immunoglobulin Gene Repertoire in Ocular Adnexa Lymphomas (OAL): Hints on the Nature of the Antigenic Stimulation 9
Genomic lesions associated with a different clinical outcome in diffuse large B-Cell lymphoma treated with R-CHOP-21 9
Genomic profiles of MALT lymphomas: variability across anatomical sites 9
Consolidation radiotherapy to bulky or semibulky lesions in the management of stage III-IV diffuse large B cell lymphomas 9
Long-lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for or failed autologous transplantation 9
Final results of the IELSG-19 randomized trial of mucosa-associated lymphoid tissue lymphoma: Improved event-free and progression-free survival with rituximab plus chlorambucil versus either chlorambucil or rituximab monotherapy 9
Le infezioni erpetiche nel paziente immunocompromesso 9
Importance of complete staging in non-Hodgkin's lymphoma presenting as a cerebral mass lesion 9
Erratum to ‘How we treat primary central nervous system lymphoma’: [ESMO Open Volume 6, Issue 4, August 2021, 100213] (ESMO Open (2021) 6(4), (S2059702921001745), (10.1016/j.esmoop.2021.100213)) 8
Deep learning-based overall survival prediction model in patients with rare cancer: a case study for primary central nervous system lymphoma 8
Gastric lymphoma: The histology report 8
Clinical Relevance of the Dose of Cytarabine in the Upfront Treatment of Primary CNS Lymphomas with Methotrexate-Cytarabine Combination 8
Immunoreactivity for cyclin D3 is frequently detectable in high-grade primary gastric lymphomas in the absence of the t(6;14)(p21.1;q32.3) chromosomal translocation 8
Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas 8
Irradiation fields and doses in glioblastoma multiforme: Are current standards adequate? 8
Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions 8
Array-CGH in diffuse large B-cell lymphomas (DLBCL) treated with R-CHOP identifies recurrent 11Q24.3 aberrations 8
Randomized phase II trial on primary chemotherapy (CHT) with high-dose methotrexate (MTX) alone or associated with high-dose cytarabine (ARAC) for patients (PTS) with primary CNS lymphoma (PCNSL) 8
Extranodal non-gastric malt lymphomas: An international survey of 278 cases. 8
Therapeutic role of rituximab in the treatment of intravascular lymphoma 8
Central nervous system marginal zone B-cell lymphoma associated with chlamydophila psittaci infection 8
Immunoglobulin gene repertoire in ocular adnexal lymphomas: hints on the nature of the antigenic stimulation 8
Helicobacter pylori eradication as exclusive treatment for limited-stage gastric diffuse large B-cell lymphoma: results of a multicenter phase 2 trial. 8
Rituximab improves outcome in Western patients with intravascular large B-cell lymphoma (IVL) 8
Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapies 8
AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell Lymphoma 8
Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma 8
Up-front chemotherapy (CHT) containing high-dose methotrexate (HDMTX) followed or not by radiotherapy (RT) in Primary CNS lymphoma (PCNSL): a critical review of prospective trials 8
RANDOMIZED PHASE II TRIAL ON PRIMARY CHEMOTHERAPY WITH HIGH-DOSE METHOTREXATE (HD-MTX) ALONE OR ASSOCIATED WITH HIGH-DOSE CYTARABINE (HD-ARAC) FOR PATIENTS WITH PRIMARY CNS LYMPHOMA (IELSG # 20 TRIAL): TOLERABILITY, ACTIVITY AND SURVIVAL ANALYSES 8
Primary central nervous system lymphoma in immunocompetent patients 8
Primary non-Hodgkin's lymphoma of the bone (PLB): Management of 21 cases 8
Systemic vs. intrathecal central nervous system prophylaxis in primary adrenal/renal diffuse large b-cell LYMPHOMA: A multi-institution retrospective analysis and systematic review 8
Targeted therapies make room, anti-CD79b agents are coming 7
Lenalidomide maintenance after autologous haematopoietic stem-cell transplantation in mantle cell lymphoma: results of a Fondazione Italiana Linfomi (FIL) multicentre, randomised, phase 3 trial 7
Radiomics-Based Machine Learning Model for Predicting Overall and Progression-Free Survival in Rare Cancer: A Case Study for Primary CNS Lymphoma Patients 7
Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy 7
Chronic idiopathic myelofibrosis: independent prognostic importance of bone marrow microvascular density evaluated by CD105 (endoglin) immunostaining 7
Immunoreactivity for p27(kip1) and cyclin E is an independent predictor of survival in primary gastric non-Hodgkin's lymphoma 7
Genetic and epigenetic changes linked to Chlamydophila psittaci-associated ocular adnexal lymphomas 7
CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study 7
Intravascular large B cell lymphoma: widespread but not everywhere 7
Prognostic significance of cancer-testis gene expression in resected non-small cell lung cancer patients. 7
Intravascular lymphoma: a neoplasm of 'homeless' lymphocytes? 7
Low sensitivity of computed tomography in the staging of gastric lymphomas of mucosa-associated lymphoid tissue - Impact on prospective trials and of ordinary clinical practice 7
Primary brain CD30+ALK1+anaplastic large cell lymphoma ('ALKoma'): the first case with a combination of 'not common' variants 7
Extranodal Lymphomas 7
Totale 1.336
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.551
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.551
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207 3 1 0 1 0 0 1 0 1 0 0 0
2020/202134 0 0 0 2 2 3 23 0 3 1 0 0
2021/2022230 0 0 2 71 9 6 15 90 4 5 1 27
2022/20231.328 620 271 55 6 9 135 42 85 53 10 17 25
2023/2024775 39 36 42 58 237 121 57 67 36 52 30 0
Totale 2.389